Tags

Type your tag names separated by a space and hit enter

Catechol O-methyltransferase inhibition and the treatment of Parkinson's disease.
Adv Pharmacol. 1998; 42:331-4.AP

Authors+Show Affiliations

Nutt JG
Department of Neurology, Oregon Health Sciences University, Portland 97201, USA.

MeSH

AnimalsAntiparkinson AgentsBlood-Brain BarrierBrainCatechol O-Methyltransferase InhibitorsCatecholsEnzyme InhibitorsHumansIntestinal AbsorptionLevodopaNitrilesParkinson DiseaseTissue Distribution

Pub Type(s)

Journal Article

Language

eng

PubMed ID

9327908

Citation

Nutt, J G.. "Catechol O-methyltransferase Inhibition and the Treatment of Parkinson's Disease." Advances in Pharmacology (San Diego, Calif.), vol. 42, 1998, pp. 331-4.
Nutt JG. Catechol O-methyltransferase inhibition and the treatment of Parkinson's disease. Adv Pharmacol. 1998;42:331-4.
Nutt, J. G. (1998). Catechol O-methyltransferase inhibition and the treatment of Parkinson's disease. Advances in Pharmacology (San Diego, Calif.), 42, 331-4.
Nutt JG. Catechol O-methyltransferase Inhibition and the Treatment of Parkinson's Disease. Adv Pharmacol. 1998;42:331-4. PubMed PMID: 9327908.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Catechol O-methyltransferase inhibition and the treatment of Parkinson's disease. A1 - Nutt,J G, PY - 1997/11/5/pubmed PY - 1997/11/5/medline PY - 1997/11/5/entrez SP - 331 EP - 4 JF - Advances in pharmacology (San Diego, Calif.) JO - Adv Pharmacol VL - 42 SN - 1054-3589 UR - https://www.unboundmedicine.com/medline/citation/9327908/Catechol_O_methyltransferase_inhibition_and_the_treatment_of_Parkinson's_disease_ L2 - https://medlineplus.gov/parkinsonsdisease.html DB - PRIME DP - Unbound Medicine ER -